Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on April 7, 2025
Shoals Technologies Group, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
April 7, 2025
PORTLAND, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2025 results before market open on Tuesday, May 6, 2025, to be followed by a …
Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer
GlobeNewswire
·
April 7, 2025
DETROIT, April 07, 2025 (GLOBE NEWSWIRE) -- Atwater Brewing, Detroit’s renowned craft brewery and a craft beer brand of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of Atwater Light, a low-calorie, low-carb addition …
Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year
GlobeNewswire
·
April 7, 2025
FRIENDSWOOD, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received a Top Workplaces USA Award for the fourth …
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
GlobeNewswire
·
April 7, 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia …
ADMA Biologics Statement on Tariffs
GlobeNewswire
·
April 7, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics …
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
GlobeNewswire
·
April 7, 2025
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as 130 days Additional interim in vivo data for a first-in-class Activin E antibody shows …
LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
GlobeNewswire
·
April 7, 2025
SEOUL, South Korea, April 07, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that it will provide its logical data management solution, the Denodo Platform, to LG U+, the mobile operator division of LG and the second-largest …
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
GlobeNewswire
·
April 7, 2025
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2% placebo-adjusted BMI reduction achieved in adult patients 18 years …
Update on Extraordinary General Meeting – Extension of Zijin Put Option and Exclusivity Arrangements
GlobeNewswire
·
April 7, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 12 March 2025 in relation to an Extraordinary General Meeting (EGM) to be held on Friday, 11 April 2025. The EGM …
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
April 7, 2025
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for …
Holding(s) in Company
GlobeNewswire
·
April 7, 2025
Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the …
Renewing Shanghai: City Projects Transform Urban Landscape
GlobeNewswire
·
April 7, 2025
SHANGHAI, April 07, 2025 (GLOBE NEWSWIRE) -- Shanghai has launched a new video series titled "Renewing Shanghai," which documents the city's urban renewal projects. A Media Snippet accompanying this announcement is available by clicking on this link. …
FTAI Aviation Ltd. Announces Timing of First Quarter 2025 Earnings and Conference Call
GlobeNewswire
·
April 7, 2025
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; the "Company" or “FTAI”) plans to announce its financial results for the first quarter 2025 after the closing of Nasdaq on Wednesday, April 30, 2025. A copy of the press release …
Telix Appoints Paul Schaffer as Chief Technology Officer
GlobeNewswire
·
April 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology …
Wesdome Gold Mines to Acquire Angus Gold; Quadruples the Eagle River Land Package
GlobeNewswire
·
April 7, 2025
All amounts are expressed in Canadian dollars unless otherwise indicated TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) and Angus Gold Inc. (TSX-V: GUS, OTC: ANGVF) (“Angus”) are …
Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 7, 2025
HUNTSVILLE, AL, April 07, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …
Parsons Awarded $24 Million Naval Medical Research Command Biodefense Contract
GlobeNewswire
·
April 7, 2025
CHANTILLY, Va., April 07, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a biological defense research contract to advance the Naval Medical Research Command’s (NMRC) mission to defend against the …
Monaco: Superyacht Chef Competition ends at the Yacht Club, zero-waste cuisine wins
GlobeNewswire
·
April 7, 2025
MONACO, April 07, 2025 (GLOBE NEWSWIRE) -- Creativity, taste, beauty, and above all, sustainability: these were the criteria used to judge the nine chefs competing in the sixth edition of the 'Superyacht Chef Competition', held at the Yacht Club de Monaco. …
Leishen Energy Holding Co., Ltd is trying to make a strategic layout in Middle East as a production base for overseas market
GlobeNewswire
·
April 7, 2025
BEIJING, April 07, 2025 (GLOBE NEWSWIRE) -- Leishen Energy is actively exploring overseas markets, especially in Middle East, and it is expected to build a manufacturing plant in Saudi Arabia next year. The Middle East is a bridge linking the Indian Ocean …
Jitterbit Earns 20 G2 Spring 2025 Badges for Leadership in Enterprise Automation, Integration and App Development
GlobeNewswire
·
April 7, 2025
ALAMEDA, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced its Harmony platform has been recognized as a leader by G2, the world's largest and most trusted …